|
0
|
|
Modeling the Impact of Case Finding for Tuberculosis: The Role of Infection Dynamics.
(academic.oup.com)
|
Ryckman TS
…
Kendall EA
Journal of Infectious Diseases
2026-04-29
|
#modeling
#infection
#epidemiology
#transmission
#tb
|
|
0
|
|
National- and State-level SARS-CoV-2 Immunity Trends From January 2020 to December 2023: a Mathematical Modeling Analysis.
(academic.oup.com)
|
Klaassen F
…
Menzies NA
Journal of Infectious Diseases
2026-04-29
|
#modeling
#infection
#vaccination
#immunity
|
|
0
|
|
Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.
(academic.oup.com)
|
Gafar F
…
Menzies D
Journal of Infectious Diseases
2026-04-29
|
#pharmacokinetics
#modeling
#clinical trial
#bioavailability
#tb
|
|
0
|
|
Digital twins in IBD-bridging data, biology and trial innovation.
(gut.bmj.com)
|
Colwill M
…
Peyrin-Biroulet L
Gut
2026-04-29
|
#modeling
#inflammation
#personalized medicine
#colitis
|
|
0
|
|
Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study.
(academic.oup.com)
|
Acosta EP
…
Kimberlin DW
Journal of Infectious Diseases
2026-04-29
|
#pharmacokinetics
#modeling
#dosing
#cmv
#prematurity
|
|
0
|
|
DeepKinomeWeb: a quantitative, panel-level platform for kinase inhibitor screening and selectivity profiling.
(academic.oup.com)
|
Eun J
…
Lee J
Nucleic Acids Research
2026-04-29
|
#modeling
#screening
#kinase
#inhibitor
#selectivity
|